JPRN-UMIN000024941
Completed
未知
Suvorexant for the treatment of insomnia in patients with psychiatric disorders - Suvorexant for insomnia in patients with psychiatric disorders
Fujita Health University School of Medicine0 sites50 target enrollmentNovember 22, 2016
Conditionspsychiatric disorders
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- psychiatric disorders
- Sponsor
- Fujita Health University School of Medicine
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients meet contraindication of suvorexant Patients with substance abuse or dependence (excluding nicotine and caffeine) meeting DSM\-IV\-TR criteria Patients having severe physical disease Patients who are pregnant or may become pregnant Patients who had made suicide attempt within the past year
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Treatment of sleep disturbance (insomnia) in patients with advanced cancer who use pain killers (opioids).The overall aim of this clinical trial is to improve the knowledge of the pharmacological treatment of insomnia in patients with advanced cancer who use opioids. Despite the high prevalence of insomnia in patients in advanced cancer, there are no randomized controlled data involving pharmacological interventions for insomnia in advanced cancer. Thus, there is a need to evaluate the effectiveness of zopiclone for insomnia patients with advanced cancer.Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2015-005306-11-NOSt. Olavs Hospital, trondheim University Hospital100
Recruiting
Phase 4
emborexant for insomnia in patients with psychiatric disorder: A 1-week, open-label studyInsomniaJPRN-UMIN000041321Fujita Health University School of Medicine100
Recruiting
Phase 1
Daridorexant to treat insomnia in patients with mild cognitive impairment and mild to moderate Alzheimer disease.Insomnia DisorderSLEEPAlzheimer DiseaseMedDRA version: 20.0Level: LLTClassification code: 10078083Term: Insomnia disorder Class: 10037175Therapeutic area: Diseases [C] - Nervous System Diseases [C10]CTIS2023-503301-10-00niversity Hospital Of Montpellier62
Not yet recruiting
Phase 1
Clinical study on the treatment of Insomnia by integrating acupuncture and moxibustion based on traditional Chinese medicine theoryinsomniaITMCTR2200005752The Hospital of Chengdu University of TCM
Completed
Not Applicable
Efficacy and safety of lemborexant in insomnia patients with nocturia.JPRN-UMIN000044383Kyowakai Medical Corporation Kyoritsu Hospital30